Jane T Hickok

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in t
    Jane T Hickok
    University of Rochester Cancer Center URCC Community Clinical Oncology Program CCOP Research Base, University of Rochester James P Wilmot Cancer Center, New York 14642, USA
    Cancer 97:2880-6. 2003
  2. ncbi request reprint Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer
    Joseph A Roscoe
    University of Rochester Cancer Center, Rochester General Hospital Cancer Center, New York 14642, USA
    J Pain Symptom Manage 29:376-84. 2005
  3. ncbi request reprint Biobehavioral factors in chemotherapy-induced nausea and vomiting
    Joseph A Roscoe
    Cancer Control Program, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Natl Compr Canc Netw 2:501-8. 2004
  4. ncbi request reprint Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer
    Jane T Hickok
    Department of Radiation Oncology and James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Pain Symptom Manage 30:433-42. 2005
  5. ncbi request reprint The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study
    Joseph A Roscoe
    University of Rochester Cancer Center, Rochester, New York 14642, USA
    J Pain Symptom Manage 26:731-42. 2003
  6. ncbi request reprint Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices
    Maarten Hofman
    University of Rochester Cancer Center, Rochester, New York 14642, USA
    Cancer 101:851-7. 2004
  7. ncbi request reprint Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy
    Joseph A Roscoe
    University of Rochester Cancer Center, 601 Elmwood Avenue, Box 704, Rochester, New York 14642, USA
    Breast Cancer Res Treat 89:243-9. 2005
  8. ncbi request reprint Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer
    Jane T Hickok
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester, Rochester, New York 14642, USA
    Cancer 104:1772-8. 2005
  9. ncbi request reprint Management of cancer-related fatigue
    Gary R Morrow
    URCC CCOP Research Base, University of Rochester Cancer Center, Rochester, New York 14642, USA
    Cancer Invest 23:229-39. 2005
  10. ncbi request reprint Community-based clinical oncology research trials for cancer-related fatigue
    Pascal Jean-Pierre
    University of Rochester Cancer Center, Rochester, New York 14642, USA
    J Support Oncol 4:511-6. 2006

Detail Information

Publications20

  1. ncbi request reprint Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in t
    Jane T Hickok
    University of Rochester Cancer Center URCC Community Clinical Oncology Program CCOP Research Base, University of Rochester James P Wilmot Cancer Center, New York 14642, USA
    Cancer 97:2880-6. 2003
    ..This study summarized the frequency, timing, and intensity of postchemotherapy nausea for patients receiving doxorubicin, cisplatin, or carboplatin...
  2. ncbi request reprint Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer
    Joseph A Roscoe
    University of Rochester Cancer Center, Rochester General Hospital Cancer Center, New York 14642, USA
    J Pain Symptom Manage 29:376-84. 2005
    ..1 for all). Study results do not support the hypothesis that acustimulation bands are efficacious as an adjunct to pharmacological antiemetics for control of chemotherapy-related nausea in female breast cancer patients...
  3. ncbi request reprint Biobehavioral factors in chemotherapy-induced nausea and vomiting
    Joseph A Roscoe
    Cancer Control Program, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Natl Compr Canc Netw 2:501-8. 2004
    ....
  4. ncbi request reprint Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer
    Jane T Hickok
    Department of Radiation Oncology and James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Pain Symptom Manage 30:433-42. 2005
    ..Improved understanding about the time course and dose response of radiation-induced toxicity will permit more accurate presentation of side effect risk at the time patient consent is obtained...
  5. ncbi request reprint The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study
    Joseph A Roscoe
    University of Rochester Cancer Center, Rochester, New York 14642, USA
    J Pain Symptom Manage 26:731-42. 2003
    ..052). Expected efficacy of the bands was related to outcomes for the acupressure but not the acustimulation conditions...
  6. ncbi request reprint Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices
    Maarten Hofman
    University of Rochester Cancer Center, Rochester, New York 14642, USA
    Cancer 101:851-7. 2004
    ..However, to the authors' knowledge, less is known regarding what patients expect to experience regarding these side effects and how patient characteristics are related to these expectations...
  7. ncbi request reprint Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy
    Joseph A Roscoe
    University of Rochester Cancer Center, 601 Elmwood Avenue, Box 704, Rochester, New York 14642, USA
    Breast Cancer Res Treat 89:243-9. 2005
    ..It commonly co-exists with depression in patients undergoing chemotherapy, suggesting that administration of an antidepressant that alleviates symptoms of depression could also reduce fatigue...
  8. ncbi request reprint Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer
    Jane T Hickok
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester, Rochester, New York 14642, USA
    Cancer 104:1772-8. 2005
    ..Patients often describe fatigue as the most distressing of the symptoms they experienced during their cancer treatment. Fatigue may increase from initial levels experienced during cancer treatment with the addition of radiotherapy (RT)...
  9. ncbi request reprint Management of cancer-related fatigue
    Gary R Morrow
    URCC CCOP Research Base, University of Rochester Cancer Center, Rochester, New York 14642, USA
    Cancer Invest 23:229-39. 2005
    ..A more thorough evaluation of the various therapeutic options is required to better define their efficacy and safety profiles in this patient population...
  10. ncbi request reprint Community-based clinical oncology research trials for cancer-related fatigue
    Pascal Jean-Pierre
    University of Rochester Cancer Center, Rochester, New York 14642, USA
    J Support Oncol 4:511-6. 2006
    ..This article will provide a description of-the NCI CCOP, its functions, and a brief overview of ongoing research on CRF both at our institution and other locations across the United States...
  11. pmc 5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial
    Jane T Hickok
    Department of Radiation Oncology and James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Lancet Oncol 6:765-72. 2005
    ..We aimed to assess whether a 5-HT-receptor antagonist was more effective than was prochlorperazine for control of delayed nausea and delayed vomiting caused by doxorubicin...
  12. pmc Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial
    Kishan J Pandya
    University of Rochester Cancer Center Community Clinical Oncology Program Research Base, University of Rochester Cancer Center, Rochester, NY 14642, USA
    Lancet 366:818-24. 2005
    ..We undertook a randomised, double-blind, placebo-controlled, multi-institutional trial to assess the efficacy of gabapentin in controlling hot flashes in women with breast cancer...
  13. ncbi request reprint Nausea and emesis: evidence for a biobehavioral perspective
    Gary R Morrow
    Cancer Control Program, University of Rochester Cancer Center, Rochester, 601 Elmwood Avenue, Box 704, Rochester, NY 14641, USA
    Support Care Cancer 10:96-105. 2002
    ..This paper draws on both physiological and psychological origins of NV to begin the development of a biobehavioral model of development that integrates features of both approaches...
  14. ncbi request reprint Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment
    Joseph A Roscoe
    Cancer Control Program, University of Rochester Cancer Center, Behavioral Medicine Unit, 601 Elmwood Avenue, Box 704, Rochester, NY 14642, USA
    Support Care Cancer 10:329-36. 2002
    ..04; FSCL r=-0.30; P=0.04; CES-D r=-0.39; P=0.008; HDI r=-0.34; P=0.03; POMS r=-0.40; P=.007). These findings provide evidence that circadian rhythm disruption is involved in the experience of fatigue and depression in cancer patients...
  15. ncbi request reprint Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program
    Gary R Morrow
    James P Wilmot Cancer Center and Department of Biostatistics, University of Rochester Medical Center, NY 14642, USA
    J Clin Oncol 21:4635-41. 2003
    ....
  16. ncbi request reprint Fatigue associated with cancer and its treatment
    Gary R Morrow
    Cancer Control Program University of Rochester Cancer Center, 601 Elmwood Avenue, Box 704, Rochester, NY 14641, USA
    Support Care Cancer 10:389-98. 2002
    ..This paper introduces four plausible hypotheses for the development of fatigue. Evidence available to support a role for anemia, adenosine triphosphate, vagal afferents, and the interaction of the HPA/cytokines and 5HT is discussed...
  17. ncbi request reprint Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea?
    Gary R Morrow
    Behavioral Medicine Unit, University of Rochester Cancer Center, New York 14642, USA
    Psychophysiology 39:491-5. 2002
    ..The possible role of this reduction in cortisol is discussed in relation to induction of chemotherapy-induced nausea and vomiting...
  18. ncbi request reprint Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma
    Joseph A Roscoe
    Behavioral Medicine Unit, University of Rochester Community Clinical Oncology Program Research Base, University of Rochester James P Wilmot Cancer Center, Rochester, New York
    Cancer 101:2701-8. 2004
    ..Mounting evidence suggests that these expectancies relating to nausea are significant predictors, and, likely, contributing factors to the development of treatment-related nausea...
  19. ncbi request reprint Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected
    Joseph A Roscoe
    University of Rochester Medical Center URCC Community Clinical Oncology Program CCOP Research Base, Rochester, NY, USA
    J Soc Integr Oncol 4:16-20. 2006
    ....
  20. ncbi request reprint Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach
    Youngmee Kim
    University of Rochester School of Medicine, New York, USA
    J Pain Symptom Manage 32:311-21. 2006
    ..Theoretical and practical implications of the current findings are discussed and suggestions for interventions to alleviate fatigue and depressive symptoms in cancer patients are proposed...